Blood Podcast cover image

Pembrolizumab plus AVD for classical Hodgkin lymphoma, targeting the CD40/CD40-ligand axis in Waldenström Macroglobulinemia, and CXCR4-expressing CAR-cytokine induced killer cells in AML

Blood Podcast

00:00

Targeting the Immune Microenvironment in Waldenstrom Macroglobulinemia

Mai and Herrera conclude that studies of treatment de-escalation could be considered in future trials of classical Hodgkin lymphoma. Waldenstrom Macroglobulinemia is a clonal B cell malignancy characterized by the accumulation of lymphoplasmacetic cells within the bone marrow, along with a serum monoclonal immunoglobulin M or IgM protein.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app